Replies to post #64393 on Anavex Life Sciences Corp (AVXL)

[neiu]

If anything, Xena would be happy as they have a partnership with Otsuka which could potentially expedite the penetration of the Japanese/Asian market. Lundbeck has gone through some rough financial times as of late and resorted on laying off 1000 people last August. Any potentially game changing drugs could turn things around and could even make partnership terms more favorable towards Anavex.

Either way, we can speculate as much as we want but the fact remains in the need to have the hard data. Though for many of us who have been here for awhile through the roller coaster ride it is important to maintain patience and perspective, and I think vigilance as well. However, I do remain cautiously optimistic. (Figured if I used a more positive leading term I might get sued)

[Amatuer17]

G you just keep on dumping this information - also try to link all the data to A2-73 and all possible indications - in reality apart from just information, it does not have much investment value - mainly because company maynot be able to do much without sufficient funds

So the co needs to focus on one indication and move trials as fast as possible - get some concrete data that shows proper efficacy and BP will come running.

You used to dump such info for K another cancer drug but even after 2 plus years - company has not moved it further so the price has remained at sub 2 level.

Maybe a scientific forum is right place to dump this information.